February 9th 2025
A population-based study led by Cedars-Sinai investigators found that thyroid cancer continues to be overdiagnosed, while the risk of dying from the disease has remained the same.
2025 GU Satellite Symposia in San Francisco
February 13-14, 2025
Register Now!
Dialogues With the Surgeon on Integration of Systemic Therapies in Perioperative Settings for NSCLC: Looking at EGFR, ALK, IO, and Beyond…
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
Study Calls for Reclassification of Thyroid Tumors as Non-Cancerous
April 22nd 2016A new study is calling for a change in name for certain thyroid tumors. Patients diagnosed with what is currently known as noninvasive encapsulated follicular variant of papillary thyroid carcinoma have a very low risk for recurrence and therefore, researchers have suggested renaming the condition.
Pre-Op Ultrasound ID’s Important Prognostic Characteristics in Thyroid Cancer
March 18th 2016Researchers have identified several characteristics of metastatic papillary thyroid cancer shown on preoperative ultrasound-such as node matting-that are associated with extranodal extension, an important prognostic factor linked with this disease.
Physical Exams Adequate to Detect Thyroid Cancer in Cancer Survivors
February 3rd 2016The use of a standard yearly physical examination to screen for thyroid cancer among high-risk survivors of childhood and young adult cancers resulted in a negative predictive value of 100% for clinically relevant thyroid cancer and a significant cost savings compared with regular ultrasound screening.
Markers in Medullary Thyroid Cancer May Signal Metastasis, Vandetanib Response
October 22nd 2015Researchers in Germany appear to have identified a gene-expression signature associated with metastasis in sporadic medullary thyroid cancer and prognostic molecular tumor markers of medullary thyroid cancer response to vandetanib therapy.
Superior Survival Seen With Aggressive Therapy in Anaplastic Thyroid Cancer
October 21st 2015For patients who can tolerate aggressive multimodal therapy for anaplastic thyroid carcinoma, survival rates can exceed historical outcomes, according to a retrospective study of patients treated at the Mayo Clinic.
Role of Fukushima Radiation Unclear in Pediatric Thyroid Cancers?
October 21st 2015It is too soon to determine the influence of radiation exposure on thyroid cancer risk among children and adolescents exposed to the 2011 Fukushima Daiichi nuclear power plant disaster in Japan, according to the lead author of findings presented at the 85th Annual Meeting of the ATA.